Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
EMERYVILLE, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it has agreed to sell an aggregate of four million shares
of its common stock at a price to the public of $30.50 per share and $200 million aggregate principal amou...
Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
KENILWORTH, N.J., June 23 /PRNewswire-FirstCall/ -- The Board of Directors of Schering-Plough Corporation (NYSE: SGP ) today declared a quarterly dividend of 6.5 cents per common share. Payment will be made on Aug. 31, 2009, to shareholders of record at the close of business on August 7, 2009. ...
Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
FRAZER, Pa., May 21 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH ) announced today the pricing of its concurrent public offerings of 5 million shares
of common stock, at a price of $60 per share, and $435 million in aggregate principal amount of 2.50% convertible senior subordinated no...
Antiviral Drugmaker Shares Soar as Swine Flu Spreads; Beacon Equity Issues Stock Alerts on: HEB, GNBT, BCRX, DVAX, NVAX, SVA
DALLAS, April 28 /PRNewswire/ -- BeaconEquity.com announces the availability of Stock Alerts on stocks making news today. As the influenza dominates the headlines, several biopharmaceutical stocks are parading up the charts.
So how does swine flu affect the markets? Check out a video chart f...
Alexandria Real Estate Equities, Inc. Announces Pricing of Public Follow-On Offering of 7,000,000 Shares of Common Stock
PASADENA, Calif., March 19 /PRNewswire-FirstCall/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE ) announced today the pricing of its follow-on public offering of 7,000,000 shares
of common stock at a price of $38.25 per share, upsized from an originally sized offering of 4,500,000 shares. ...
Endo Pharmaceuticals Extends Subsequent Offering Period for Indevus Shares Until 5:00 pm EDT on Wednesday, March 18, 2009
Announces that Approximately 89.3 Percent of Outstanding Indevus Shares
Have Been Accepted for Purchase
CHADDS FORD, Pa., March 16 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that, as of 5:00 p.m., New York City time, on March 13, 2009, approximately 71,00...
Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Indevus Pharmaceuticals and Announces Subsequent Offering Period
CHADDS FORD, Pa., Feb. 23 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP ) today announced the successful completion of the tender offer by its wholly owned subsidiary, BTB Purchaser Inc., for all of the outstanding shares
of common stock of Indevus Pharmaceuticals, Inc. (Nasdaq: ...
InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock
BRISBANE, Calif., Feb. 13 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced the pricing of an underwritten public offering of 3,500,000 shares
of its common stock. The last reported sale price of InterMune's common stock on the NASDAQ Global Select Market on February 12,...
New Study Shares Benchmarks for Fixed-Dose Combination (FDC) Drug Development
CHAPEL HILL, N.C., Feb. 5 /PRNewswire/ -- As biopharmaceutical companies
focus on line extensions and new product development opportunities, fixed-dose
combination (FDC) products have become an increasingly important segment of
the market. In an effort to better understand the development str...
New Study Shares Insights for Competitive Intelligence Policies, Ethics and Data Collection
CHAPEL HILL, N.C., Jan. 30 /PRNewswire/ -- New research has shown that companies can take advantage of opportunities and manage risk by collecting and understanding intelligence through the competitive or business intelligence function. In an effort to better understand the best practices in de...
Roche Intends to Commence Tender Offer to Acquire All Shares of Genentech for US$ 86.50 Per Share in Cash
BASEL, Switzerland, Jan. 30 /PRNewswire/ -- Roche announced today that it intends to commence a cash tender offer for all outstanding publicly-held shares
of Genentech at US$ 86.50 per share. Roche, which currently owns 55.8% of the Genentech outstanding shares, expects to commence the tender offe...
BVF Acquisition LLC, a Wholly-Owned Subsidiary of Biotechnology Value Fund, L.P., Commences Tender Offer for Any and All Outstanding Shares of Avigen at $1.00 Per Share
NEW YORK, Jan. 23 /PRNewswire/ -- BVF Acquisition LLC (the "Purchaser"), a wholly owned subsidiary of Biotechnology Value Fund, L.P. ("BVF"), announced today that it has commenced a cash tender offer to purchase any and all of the outstanding common stock of Avigen, Inc. (Nasdaq: AVGN ) ("Avigen...
Biotechnology Value Fund, L.P. To Make Tender Offer For Any And All Outstanding Shares Of Avigen At $1.00 Per Share
Tender Offer provides stockholders with a near-term cash alternative if BVF nominees are elected
BVF reaffirms support for downside-protected merger with MediciNova
NEW YORK, Jan. 15 /PRNewswire/ -- Biotechnology Value Fund, L.P. ("BVF") announced today that it intends to make a cash te...
Jatropha Sector Reality Check: Still Viable In Volatile Times? Upcoming Webcast Shares Latest Insights
In this time of global economic uncertainty, a top question of Jatropha developers is, "What impact will the current economic crisis have on the Jatropha sector and its prominence as a viable, sustainable biofuel?" To address this critical concern and more, a free 20 January webinar has...
GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.
LONDON, Jan. 7 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (LSE/NYSE: GSK ) announced today the successful completion of the tender offer by its wholly-owned subsidiary Gemstone Acquisition Corporation for shares
of common stock of Genelabs Technologies, Inc. (Nasdaq: GNLB ). The tender offe...
Roche Purchases Shares in Tender Offer For Memory Pharmaceuticals Corp.
NUTLEY, N.J. and BASEL, Switzerland, Jan. 2 /PRNewswire-FirstCall/ -- Roche (SWX: ROG.VX; RO.S; OTCQX; RHHBY) today announced that its wholly-owned subsidiary 900 North Point Acquisition Corporation has accepted for payment all shares
validly tendered and not withdrawn pursuant to its tender offer...
Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
KENILWORTH, N.J., Dec. 10 /PRNewswire-FirstCall/ -- The Board of Directors of Schering-Plough Corporation (NYSE: SGP ) today declared a quarterly dividend of 6.5 cents per common share. Payment will be made on Feb. 27, 2009, to shareholders of record at the close of business on Feb. 6, 2009. A...
Best Practice Database Shares Best Practices in Biopharma Public Relations
CHAPEL HILL, N.C., Nov. 13 /PRNewswire/ -- Bio-Pharma executives are
increasingly finding value in the research products and services offered by
Best Practices, LLC and in particular in use of the on-demand benchmark
repository known as the Best Practice Database.
New Study Shares Best Practices in Biopharma Public Relations
CHAPEL HILL, N.C., Nov. 6 /PRNewswire/ -- While Public Relations has
long been used as a marketing tool by the pharmaceutical and biotechnology
industries, its ability to reach consumers has never been greater. Web
sites, online social networks, and blogs have joined the traditional press
Biomoda, Inc. (BMOD) SqueezeTrigger Price is $0.27. Approximately 1 Million Shares Shorted Since November 2006 According to Buyins.net Research Report
ALBUQUERQUE, N.M., Nov. 3 /PRNewswire-FirstCall/ -- Biomoda, Inc. (OTC
Bulletin Board: BMOD) ( http://www.biomoda.com ), a development stage medical
diagnostics company, announced today that BUYINS.NET,
http://www.buyins.net, is initiating coverage of Biomoda after releasing
the latest short...
Can Algae Biofuels Satisfy the World's Growing Biofuel Needs? Upcoming Webinar Shares the Latest Commercialization Strategies and Challenges
Two leading Algae experts will share their views on the commercialization prospects of Algae Biofuels at the upcoming "Algae Biofuels: The REAL Story" webinar. This webinar separates facts from fiction and will provide a critical examination of several key issues central to long-term co...
GSI Group Accepts Shares in Tender Offer for Excel Technology and Commences Subsequent Offering Period
BEDFORD, Mass., Aug. 20 /PRNewswire-FirstCall/ -- GSI Group Inc.
(Nasdaq: GSIG ) announced today the expiration of the initial offering
period of the tender offer by its indirect wholly-owned subsidiary Eagle
Acquisition Corporation (EAC) for all outstanding shares
of common stock of
Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash
- Combination to enhance innovation by allowing for diversity of research
approaches while also encouraging sharing of IP, technologies, partnerships and other key assets - Improved operational efficiency to result from reduced complexity, elimination of duplication...
Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period
BEDFORD, Mass. and MADISON, Wis., July 17 /PRNewswire-FirstCall/ --
Hologic, Inc. (Nasdaq: HOLX ) and Third Wave Technologies, Inc. (Nasdaq:
TWTI) ("Third Wave"), today jointly announced the expiration of the initial
offering period of the tender offer by its wholly-owned subsidiary Thunder
Warburg Pincus Acquires 5.4% of WuXi PharmaTech's Outstanding Ordinary Shares from United Overseas Bank
SHANGHAI, China, July 14 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE:
WX), a leading pharmaceutical, biotechnology and medical device research
and development outsourcing company with operations in China and the United
States, today announced that Warburg Pincus, the global private equity
Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
KENILWORTH, N.J., June 24 /PRNewswire-FirstCall/ -- The Board of
Directors of Schering-Plough Corporation (NYSE: SGP ) today declared a
quarterly dividend of 6.5 cents per common share. Payment will be made on
Aug. 26, 2008, to shareholders of record at the close of business on Aug.
1, 2008. ...
CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Company's Common Stock and Trading in Post-split Shares Begins May 9, 2008
Split Intended to Maintain Nasdaq Listing and Attract Additional Investors as Company Enters Next Growth Phase
SAN DIEGO, May 8 /PRNewswire-FirstCall/ -- CardioDynamics (Nasdaq:
CDIC), the innovator and leader of BioZ(R) impedance cardiography (ICG)
technology, today announced ...
Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder
NANJING, CHINA, April 28 /PRNewswire-FirstCall/ -- Simcere
Pharmaceutical Group (NYSE: SCR ), a leading manufacturer and supplier of
branded generic pharmaceuticals and manufacturer of the patented
anti-cancer biotech product Endu in China, today announced that it has been
informed that one o...
BioMed Realty Trust Prices Public Offering of 5,700,000 Shares of Common Stock
SAN DIEGO, April 17 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc.
(NYSE: BMR ) today announced the pricing of its public offering of 5,700,000
shares of common stock at $25.50 per share. The offering is expected to
close on or about April 22, 2008. Gross proceeds from the offering will ...
Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period
Subsequent Offering Period Expires on Tuesday, April 1, 2008
LEVERKUSEN, Germany, and PITTSBURGH, Pennysylvania, March 26
/PRNewswire-FirstCall/ -- Bayer HealthCare affiliate MEDRAD, Inc. announced
today that it has successfully completed its tender offer for the
SBT Acquisition Inc. Successfully Completes Tender Offer for Shares of Lifecore Biomedical, Inc.
NEW YORK, March 21 /PRNewswire/ -- SBT Acquisition Inc., a wholly owned
subsidiary of SBT Holdings Inc., which is wholly owned by Warburg Pincus
Private Equity IX, L.P., has successfully completed the tender offer for
all of the outstanding shares
of common stock of Lifecore Biomedical, Inc.
PPD Announces Plan to Repurchase Shares of its Common Stock
WILMINGTON, N.C., Feb. 20 /PRNewswire-FirstCall/ -- PPD, Inc. (Nasdaq:
PPDI) today announced its plans to begin a stock repurchase program whereby
up to $350 million of its common stock may be purchased from time to time
in the open market.
The company made the decision to initiate a share r...
Medarex Announces Completion of Sale of Shares in Genmab A/S
PRINCETON, N.J., Feb. 1 /PRNewswire-FirstCall/ -- Medarex, Inc.
(Nasdaq: MEDX ) announced today that it has completed the sale of
approximately 2.5 million shares
of Genmab A/S which stock is traded on the
Copenhagen Stock Exchange. The trade is expected to settle on February 1,
Discas, Inc. Sells Shares to SNX Organic Fertilizers, Inc.
NEW YORK, Nov. 9 /Xinhua-PRNewswire-FirstCall/ -- Discas, Inc. (Pink
Sheets: DSCS.PK), ("the Company") announced today that on November 6, 2007,
it entered into a stock purchase agreement with SNX Organic Fertilizers,
Inc., ("SNXOF"), a Delaware corporation. SNXOF's sole asset is Beijing Shen
Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
EMERYVILLE, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Bionovo, Inc.
(Nasdaq: BNVI ) (the "Company") today announced that it has priced a public
offering of 10,000,000 shares
of common stock at a price to the public of
$2.50 per share and 5,000,000 warrants to purchase shares
of common stock
Neuralstem Shares Accepted for Trading on Amex(R)
ROCKVILLE, Md., Aug. 24 /PRNewswire-FirstCall/ -- Stem cell company
Neuralstem, Inc. (OTC Bulletin Board: NRLS) today announced that its shares
have been accepted for listing on the American Stock Exchange(R) (Amex(R))
under the symbol CUR. Neuralstem shares
are expected to begin trading on
AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol 'APPY'
CASTLE ROCK, Colo., Aug. 23 /PRNewswire-FirstCall/ -- AspenBio Pharma,
Inc. (OTC Bulletin Board: APNB) an emerging bio-pharmaceutical company
dedicated to the development of novel drugs and diagnostics for animals and
humans, today announced its application to list its common stock on the
Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
IRVING, Texas, Aug. 16 /PRNewswire-FirstCall/ Carrington Laboratories,
Inc., a global provider of medical, nutraceutical, consumer and raw
material products, announced today that it received a letter from The
Nasdaq Stock Market informing the Company that Nasdaq has determined to
delist the se...
Nutrition 21 Redeems Series I Convertible Preferred Shares
PURCHASE, N.Y., April 1 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. (Nasdaq: NXXI ), a developer and marketer of nutritional supplements that help consumers manage blood sugar levels, improve cardiovascular health, enhance memory and address chronic joint pain, announced today that on March 31,...
China Medical Technologies Senior Management Purchased Company Shares
BEIJING, March 6 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,
Inc. (the "Company") (Nasdaq: CMED ), a leading China-based medical device
company that develops, manufactures and markets advanced in-vitro diagnostic
products, today announced that each of Mr. Xiaodong Wu, the Comp...